Citation Impact
Citing Papers
CD8+ T Cells Specific for Tumor Antigens Can Be Rendered Dysfunctional by the Tumor Microenvironment through Upregulation of the Inhibitory Receptors BTLA and PD-1
2011
Immunotype and Immunohistologic Characteristics of Tumor-Infiltrating Immune Cells Are Associated with Clinical Outcome in Metastatic Melanoma
2012
Mouse models of acute and chronic hepacivirus infection
2017 StandoutScienceNobel
Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)
2013 StandoutNobel
The oncogenic role of hepatitis delta virus in hepatocellular carcinoma
2019
COVID-19 and liver disease: mechanistic and clinical perspectives
2021
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies
2018 StandoutNobel
Triple-Negative Breast Cancer
2010 Standout
The Spring α-Helix Coordinates Multiple Modes of HCV (Hepatitis C Virus) NS3 Helicase Action
2016 StandoutNobel
The molecular underpinning of lobular histological growth pattern: a genome‐wide transcriptomic analysis of invasive lobular carcinomas and grade‐ and molecular subtype‐matched invasive ductal carcinomas of no special type
2009
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Yttrium-90 microspheres for the treatment of hepatocellular carcinoma: A review
2006
Hepatocellular carcinoma
2018 Standout
Acute-on-chronic liver failure: A distinct clinical syndrome
2021
Restoration of HCV-specific CD8+ T cell function by interferon-free therapy
2014
T cell exhaustion
2011 Standout
Analysis of CD8+ T-Cell–Mediated Inhibition of Hepatitis C Virus Replication Using a Novel Immunological Model
2008
Hepatitis C virus induces interferon-λ and interferon-stimulated genes in primary liver cultures
2010 StandoutNobel
Regulatory T Cells
2010
Immunodominance and functional alterations of tumor-associated antigen-specific CD8+ T-cell responses in hepatocellular carcinoma
2013
Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease
2018
Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies
2007 StandoutNobel
The COVID-19 pandemic will have a long-lasting impact on the quality of cirrhosis care
2020
The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis
2020
Hepatocellular carcinoma
2021 Standout
TCF1+ hepatitis C virus-specific CD8+ T cells are maintained after cessation of chronic antigen stimulation
2017
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
Hepatitis C Virus Continuously Escapes From Neutralizing Antibody and T-Cell Responses During Chronic Infection In Vivo
2006 StandoutNobel
Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection
2006 StandoutNobel
Programmed death-1 upregulation is correlated with dysfunction of tumor-infiltrating CD8+ T lymphocytes in human non-small cell lung cancer
2010
PD-1/PD-L1 pathway and T-cell exhaustion in chronic hepatitis virus infection
2010
Mailed Outreach Program Increases Ultrasound Screening of Patients With Cirrhosis for Hepatocellular Carcinoma
2016
Biological Functions of Autophagy Genes: A Disease Perspective
2019 Standout
Pathological bacterial translocation in liver cirrhosis
2013
Hepatocellular Carcinoma Risk Declines but Remains High Enough for Screening in the First 7 Years After Hepatitis C Virus Cure With Direct-Acting Antivirals in Patients With Cirrhosis or High Fibrosis-4 Score
2022
Non-alcoholic fatty liver disease
2021 Standout
Redefining Chronic Viral Infection
2009
Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence
2009
Adaptive Immunity to the Hepatitis C Virus
2010
T cell exhaustion during persistent viral infections
2015
The Impact of the Gut Microbiota on Human Health: An Integrative View
2012 Standout
The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development
2014
Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells
2013
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
2015 Standout
Global burden of liver disease: 2023 update
2023 Standout
Enhanced Activation of Memory, but Not Naïve, B Cells in Chronic Hepatitis C Virus-Infected Patients with Cryoglobulinemia and Advanced Liver Fibrosis
2013 StandoutNobel
Cancer immunotherapy comes of age
2011 StandoutNature
Inhibitory Molecules That Regulate Expansion and Restoration of HCV-Specific CD4+ T Cells in Patients With Chronic Infection
2011
Lipophagy and liver disease: New perspectives to better understanding and therapy
2017
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
Innate and adaptive immune responses in HCV infections
2014
Failure of innate and adaptive immune responses in controlling hepatitis C virus infection
2011
Gastric cancer
2020 Standout
Effects of antiviral therapy on the cellular immune response in acute hepatitis C
2004
A Role for the Transcriptional Repressor Blimp-1 in CD8+ T Cell Exhaustion during Chronic Viral Infection
2009
Hepatocellular carcinoma in Ghana: a retrospective analysis of a tertiary hospital data
2020
Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer
2017 StandoutNobel
The Immunoregulatory Role of CD244 in Chronic Hepatitis B Infection and its Inhibitory Potential on Virus-Specific CD8+ T-cell Function
2010
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
2014 Standout
Antigen‐specific T lymphocyte proliferation decreases over time in advanced chronic hepatitis C
2011
A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C
2013
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
2015 StandoutNature
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
The diversity of costimulatory and inhibitory receptor pathways and the regulation of antiviral T cell responses
2009
Coexpression of PD-1, 2B4, CD160 and KLRG1 on Exhausted HCV-Specific CD8+ T Cells Is Linked to Antigen Recognition and T Cell Differentiation
2010
Epidemiology and surveillance for hepatocellular carcinoma: New trends
2020
A genetically humanized mouse model for hepatitis C virus infection
2011 StandoutNatureNobel
Inhibitory Phenotype of HBV-Specific CD4+ T-Cells Is Characterized by High PD-1 Expression but Absent Coregulation of Multiple Inhibitory Molecules
2014
Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma
2018
T cell responses in hepatitis C: the good, the bad and the unconventional
2011
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Sorafenib with or without concurrent transarterial chemoembolization in patients with advanced hepatocellular carcinoma: The phase III STAH trial
2018
HCV and the hepatic lipid pathway as a potential treatment target
2011
Spontaneous Clearance of Chronic Hepatitis C Virus Infection Is Associated With Appearance of Neutralizing Antibodies and Reversal of T-Cell Exhaustion
2012
Synergistic Reversal of Intrahepatic HCV-Specific CD8 T Cell Exhaustion by Combined PD-1/CTLA-4 Blockade
2009
Antiviral Intrahepatic T-Cell Responses Can Be Restored by Blocking Programmed Death-1 Pathway in Chronic Hepatitis B
2009
A Randomized, Double-Blind, Placebo-Controlled Assessment of BMS-936558, a Fully Human Monoclonal Antibody to Programmed Death-1 (PD-1), in Patients with Chronic Hepatitis C Virus Infection
2013
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Hepatocellular Carcinoma
2019 Standout
Prevalence of Hepatitis B and Hepatitis D Virus Infections in the United States, 2011–2016
2019
Detection of self-reactive CD8 + T cells with an anergic phenotype in healthy individuals
2014 StandoutScienceNobel
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Head and Neck Cancer
2020 Standout
Selective expansion of a subset of exhausted CD8 T cells by αPD-L1 blockade
2008
HURLER'S SYNDROME: A GENETIC STUDY OF CLONES IN CELL CULTURE WITH PARTICULAR REFERENCE TO THE LYON HYPOTHESIS
1967
Economic and Clinical Burden of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes in the U.S.
2019
Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia
2007 StandoutNobel
Impact of COVID‐19 Pandemic on Liver Transplantation and Alcohol‐Associated Liver Disease in the USA
2021
Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems
2014 StandoutNobel
Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C
2005 StandoutNobel
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
2012 StandoutNobel
Modeling hepatitis C virus infection using human induced pluripotent stem cells
2012 StandoutNobel
Burden of Illness and Economic Model for Patients With Nonalcoholic Steatohepatitis in the United States
2018
Strength of PD-1 signaling differentially affects T-cell effector functions
2013
Expression of Two X-Linked Genes in Human Hair Follicles of Double Heterozygotes
1971 StandoutNobel
Progenitor and Terminal Subsets of CD8 + T Cells Cooperate to Contain Chronic Viral Infection
2012 Science
Spontaneous Recovery in Acute Human Hepatitis C Virus Infection: Functional T-Cell Thresholds and Relative Importance of CD4 Help
2007
CD25 Blockade Depletes and Selectively Reprograms Regulatory T Cells in Concert with Immunotherapy in Cancer Patients
2012
The future of immune checkpoint therapy
2015 StandoutScienceNobel
Characteristics of splenic CD8+ T cell exhaustion in patients with hepatitis C
2013
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
2010 StandoutNobel
The Frequency of CD127 + Hepatitis C Virus (HCV)-Specific T Cells but Not the Expression of Exhaustion Markers Predicts the Outcome of Acute HCV Infection
2013 StandoutNobel
Tissue-Specific Differences in PD-1 and PD-L1 Expression during Chronic Viral Infection: Implications for CD8 T-Cell Exhaustion
2009
Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures
2010 StandoutNobel
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
2014 Standout
Mutations in Hepatitis C Virus E2 Located outside the CD81 Binding Sites Lead to Escape from Broadly Neutralizing Antibodies but Compromise Virus Infectivity
2009 StandoutNobel
Comorbid Chronic Diseases and Survival in Compensated and Decompensated Cirrhosis: A Population-Based Study
2022
A spatial view of the CD8+ T‐cell response: the case of HCV
2011
Cisplatin Every 3 Weeks Versus Weekly With Definitive Concurrent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck
2018
Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity
2017 StandoutNobel
Liver diseases: A major, neglected global public health problem requiring urgent actions and large‐scale screening
2018
Alcohol‐associated liver disease in the United States is associated with severe forms of disease among young, females and Hispanics
2021
Previously Infected Chimpanzees Are Not Consistently Protected against Reinfection or Persistent Infection after Reexposure to the Identical Hepatitis C Virus Strain
2008
Works of David E. Kaplan being referenced
Effects of Hypercholesterolemia and Statin Exposure on Survival in a Large National Cohort of Patients With Cirrhosis
2019
Rising incidence of hepatocellular carcinoma: the role of hepatitis B and C; the impact on transplantation and outcomes
2003
Association of Provider Specialty and Multidisciplinary Care With Hepatocellular Carcinoma Treatment and Mortality
2017
Discordant Role of CD4 T-Cell Response Relative to Neutralizing Antibody and CD8 T-Cell Responses in Acute Hepatitis C
2006
Incidence and Mortality of Acute‐on‐Chronic Liver Failure Using Two Definitions in Patients with Compensated Cirrhosis
2019
Dysfunctional B-cell activation in cirrhosis resulting from hepatitis C infection associated with disappearance of CD27-Positive B-cell population
2011
T‐cell response relative to genotype and ethnicity during antiviral therapy for chronic hepatitis C†
2005
Development and Performance of an Algorithm to Estimate the Child-Turcotte-Pugh Score From a National Electronic Healthcare Database
2015
Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients With Baseline Cirrhosis or High FIB-4 Scores
2019
Healthcare Costs Related to Treatment of Hepatocellular Carcinoma Among Veterans With Cirrhosis in the United States
2017
Risk Factors and Incidence of Gastric Cancer After Detection of Helicobacter pylori Infection: A Large Cohort Study
2019
Homeostasis of peripheral FoxP3+ CD4+ regulatory T cells in patients with early and late stage breast cancer
2009
Declining Cirrhosis Hospitalizations in the Wake of the COVID-19 Pandemic: A National Cohort Study
2020
Focal Distribution of Hepatitis C Virus RNA in Infected Livers
2009
Functional Restoration of HCV-Specific CD8 T Cells by PD-1 Blockade Is Defined by PD-1 Expression and Compartmentalization
2008
Do statins reduce hepatitis C RNA titers during routine clinical use?
2009
Expansion of interferon-gamma-producing multifunctional CD4+ T-cells and dysfunctional CD8+ T-cells by glypican-3 peptide library in hepatocellular carcinoma patients
2011
Delta hepatitis within the Veterans Affairs medical system in the United States: Prevalence, risk factors, and outcomes
2015
Peripheral virus-specific T-cell interleukin-10 responses develop early in acute hepatitis C infection and become dominant in chronic hepatitis
2008
Collapse of the CD27+ B-Cell Compartment Associated with Systemic Plasmacytosis in Patients with Advanced Melanoma and Other Cancers
2009
T2 Hepatocellular Carcinoma Exception Policies That Prolong Waiting Time Improve the Use of Evidence-based Treatment Practices
2020
Identifying barriers to hepatocellular carcinoma surveillance in a national sample of patients with cirrhosis
2016
Global Gene Expression Profiling Unveils S100A8/A9 as Candidate Markers in H-Ras-Mediated Human Breast Epithelial Cell Invasion
2008
Strain-Specific T-Cell Suppression and Protective Immunity in Patients with Chronic Hepatitis C Virus Infection
2005
THE GENETIC MUCOPOLYSACCHARIDOSES
1965
409 Differential mechanism of interferon-induced and spontaneous clearance of hepatitis C virus infection
2003
Impact of SGLT2 inhibitors in comparison with DPP4 inhibitors on ascites and death in veterans with cirrhosis on metformin
2021
Starting Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma: A Retrospective, Multi-Institutional Study
2017
Quality Measures, All‐Cause Mortality, and Health Care Use in a National Cohort of Veterans With Cirrhosis
2019